- Report
- October 2024
- 195 Pages
Global
From €3234EUR$3,545USD£2,781GBP
€3594EUR$3,939USD£3,090GBP
- Report
- November 2024
- 130 Pages
Global
From €5428EUR$5,950USD£4,668GBP
- Report
- April 2025
- 116 Pages
Global
From €4972EUR$5,450USD£4,276GBP
- Report
- April 2025
- 136 Pages
Global
From €2736EUR$2,999USD£2,353GBP
- Drug Pipelines
- July 2024
- 150 Pages
Global
From €3421EUR$3,750USD£2,942GBP
- Report
- April 2025
- 200 Pages
Global
From €4096EUR$4,490USD£3,523GBP
- Clinical Trials
- December 2024
- 60 Pages
Global
From €1368EUR$1,500USD£1,177GBP
- Drug Pipelines
- November 2024
- 60 Pages
Global
From €1368EUR$1,500USD£1,177GBP
- Drug Pipelines
- August 2024
- 60 Pages
Global
From €1368EUR$1,500USD£1,177GBP
- Drug Pipelines
- July 2024
- 80 Pages
Global
From €1825EUR$2,000USD£1,569GBP
- Drug Pipelines
- July 2024
- 60 Pages
Global
From €1140EUR$1,250USD£981GBP
- Clinical Trials
- June 2024
- 60 Pages
Global
From €1140EUR$1,250USD£981GBP
- Report
- January 2025
- 250 Pages
Global
From €4561EUR$4,999USD£3,922GBP
- Report
- July 2024
- 227 Pages
Global
From €4557EUR$4,995USD£3,919GBP
- Report
- October 2024
- 188 Pages
Global
From €3234EUR$3,545USD£2,781GBP
€3594EUR$3,939USD£3,090GBP
- Report
- October 2024
- 196 Pages
Global
From €3234EUR$3,545USD£2,781GBP
€3594EUR$3,939USD£3,090GBP
- Report
- October 2024
- 186 Pages
Global
From €3234EUR$3,545USD£2,781GBP
€3594EUR$3,939USD£3,090GBP
- Report
- October 2024
- 189 Pages
Global
From €3234EUR$3,545USD£2,781GBP
€3594EUR$3,939USD£3,090GBP
- Report
- October 2024
- 193 Pages
Global
From €3234EUR$3,545USD£2,781GBP
€3594EUR$3,939USD£3,090GBP
- Report
- October 2024
- 194 Pages
Global
From €3234EUR$3,545USD£2,781GBP
€3594EUR$3,939USD£3,090GBP

The Infectious Diseases Drugs market is a subset of the pharmaceutical industry that focuses on the development and production of drugs used to treat infectious diseases. These drugs are used to treat a wide range of infections, including bacterial, viral, fungal, and parasitic infections. The market is highly competitive, with many companies vying for market share. Companies in the market are typically focused on developing new drugs, as well as improving existing treatments. Additionally, many companies are involved in the production of generic drugs, which are often cheaper than brand-name drugs.
Companies in the Infectious Diseases Drugs market include Pfizer, Merck, GlaxoSmithKline, Sanofi, AstraZeneca, Novartis, Johnson & Johnson, and Bristol-Myers Squibb. Show Less Read more